Citations

Showing 10 of 108162 citations.

Absence seizures and their relationship to depression and anxiety: Evidence for bidirectionality
Gruenbaum, Benjamin F. , Sandhu, Mani Ratnesh S. , Bertasi, Raphael A.O. , Bertasi, Tais G.O. , Schonwald, Antonia, Kurup, Anirudh, Gruenbaum, Shaun E. , Freedman, Isaac G. , Funaro, Melissa , Blumenfeld, Hal , Sanacora, Gerard , Freedman, Isaac , Bertasi, Tais Garcia de Oliveira , Gruenbaum, Benjamin Fredrick

Mayo Clinic

Epilepsia | March 10, 2021 | Volume: 62 | Issue: 5 | Pages: 1041-1056

10.1111/epi.16862 | PMID 33751566 Get It

AbstractAbsence seizures (AS), presenting as short losses of consciousness with staring spells, are a common manifestation of childhood epilepsy that is associated with behavioral, emotional, and social impairments. It has also been suggested that patients with AS are more likely to suffer from mood disorders such as depression and anxiety. This systematic review and meta‐analysis synthesizes human and animal models that investigated mood disorders and AS. Of the 1019 scientific publications identified, 35 articles met the inclusion criteria for this review. We found that patients with AS had greater odds of developing depression and anxiety when compared to controls (odds ratio = 4.93, 95% confidence interval = 2.91–8.35, p < .01). The included studies further suggest a strong correlation between AS and depression and anxiety in the form of a bidirectional relationship. The current literature emphasizes that these conditions likely share underlying mechanisms, such as genetic predisposition, neurophysiology, and anatomical pathways. Further research will clarify this relationship and ensure more effective treatment for AS and mood disorders.
Gastric accommodation influences proximal gastric and total gastric emptying in concurrent measurements conducted in healthy volunteers
Burton, Duane D. , Breen‐Lyles, Margaret K., Camilleri, Michael , Breen-Lyles, Margaret, Camilleri, M , Wang, Xiao‐Jing

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | March 10, 2021 | Volume: 320 | Issue: 5 | Pages: G759-G767

10.1152/ajpgi.00008.2021 | PMID 33719546 Get It

In vivo human studies evaluated concurrently the volume of the stomach during fasting and after a solid and liquid meal using a new SPECT-based method. Although fasting gastric volumes did not impact the rates of gastric emptying, both postprandial and accommodation volumes of the whole and proximal stomach were significantly correlated with gastric emptying. Larger stomach volumes were associated with slower gastric emptying.
Three‐Dimensional Doppler Mapping of Placental Chorioangioma Prior to Fetoscopic Laser Ablation
Czeresnia, Ricardo Mamber , Trad, Ayssa Teles Abrão , Wyatt, Michelle A. , Ruano, Rodrigo , Narang, Kavita , Wyatt, Michelle, Ruano, Rodrigo

Mayo Clinic

Journal of Ultrasound in Medicine | March 10, 2021 | Volume: 41 | Issue: 1 | Pages: 255-257

10.1002/jum.15680 | PMID 33749868 Get It

Laryngotracheal Reconstruction in a Patient With a Central Conducting Lymphatic Anomaly
Macielak, Robert J. , Low, Christopher M. , Tollefson, Megha M. , Balakrishnan, Karthik , Balakrishnan, Karthik

Mayo Clinic

The Laryngoscope | March 10, 2021 | Volume: 131 | Issue: 4 | Pages: No page available

10.1002/lary.29071 | PMID 32902851 Get It

The importance of palpation in the skin cancer screening examination
Gorman, Benjamin G. , Hanson, Jennifer M., Vidal, Nahid Y. , Hanson, Jennifer

Mayo Clinic

Journal of Cosmetic Dermatology | March 10, 2021 | Volume: 20 | Issue: 12 | Pages: 3982-3985

10.1111/jocd.14054 | PMID 33751721 Get It

AbstractWith the recent unprecedented shift toward contactless healthcare solutions, providers should recall the value that proper palpation adds to dermatologic practice. We present a case that demonstrates the limitations of touchless care and how proper palpation during skin cancer examinations may impact cosmetic outcomes. Our patient is an 86‐year‐old male patient with Sezary syndrome and monoclonal B‐cell lymphocytosis whose squamous cell carcinoma invasion was missed by visual inspection alone. He delayed treatment of his biopsy‐proven squamous cell carcinoma for 15 months. On follow‐up, visual examination only showed a well‐healed biopsy scar, and treatment was delayed another 2 months. Finally, thorough physical examination found perineural invasion. This helped guide the Mohs approach, but due to the delays resulted in a larger final defect and poorer cosmetic outcomes. Proper, deep palpation of skin lesions, especially prior biopsy sites, is imperative to the treatment of skin cancer in cosmetically sensitive areas. Biopsy scars on the face often heal well, and visual only inspection may miss crucial details. This case also reminds dermatologists of the importance of patient education in the prompt treatment of skin cancer for the best cosmetic outcomes.
Safety of fibrates in cholestatic liver diseases
Carrion, Andres F. , Lindor, Keith D. , Levy, Cynthia , Levy, Cynthia

Mayo Clinic

Liver International | March 10, 2021 | Volume: 41 | Issue: 6 | Pages: 1335-1343

10.1111/liv.14871 | PMID 33751787 Get It

AbstractBackground and aimOff‐label use of fibrates in patients with cholestatic liver diseases results in improved biochemical parameters and pruritus; however, their safety in this population has been a concern. This study summarizes safety data for fibrates when used for treatment of cholestatic liver diseases.MethodsA systematic review of published studies evaluating the use of fibrates for treatment of primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) was performed. Electronic databases were searched up to December 2019 for published studies evaluating treatment outcomes associated to fibrates for these 2 diseases.ResultsA total of 37 studies were identified, including 31 for PBC and 6 for PSC, with a total of 1107 unique patients treated with fibrates ± ursodeoxycholic acid (UDCA). Most studies evaluated fenofibrate and bezafibrate, and only 1 study evaluated pemafibrate. There were no studies evaluating gemfibrozil or clofibrate. The most commonly reported adverse events (AEs) were gastrointestinal and musculoskeletal. Elevations of aminotransferases and serum creatinine were reported more commonly in patients treated with UDCA plus fibrates versus UDCA monotherapy.ConclusionsFibrates appear to be safe and well tolerated in patients with PBC, with a low frequency of AEs. There are scarce data about the safety of these agents for treatment of PSC.
Motor Speech Disorders and Communication Limitations in Progressive Supranuclear Palsy
Clark, Heather M. , Utianski, Rene L. , Ali, Farwa , Botha, Hugo , Whitwell, Jennifer L. , Josephs, Keith A. , Utianski, Rene L , Botha, Hugo , Clark, Heather M , Whitwell, Jennifer L.

Mayo Clinic

American Journal of Speech-Language Pathology | March 10, 2021 | Volume: 30 | Issue: 3S | Pages: 1361-1372

10.1044/2020_ajslp-20-00126 | PMID 33719524 Get It

Purpose This study describes motor speech disorders and associated communication limitations in six variants of progressive supranuclear palsy (PSP). Method The presence, nature, and severity of dysarthria and apraxia of speech (AOS) were documented, along with scores on the Apraxia of Speech Rating Scale–Version 3 (ASRS-3) for 77 (40 male and 37 female) patients with PSP. Clinician-estimated and patient-estimated communication limitations were rated using the Motor Speech Disorders Severity Rating (MSDSR) Scale and the Communicative Effectiveness Survey (CES), respectively. Descriptive statistics were calculated for each of these dependent variables. One-tailed t tests were conducted to test mean differences in ASRS-3 and CES between participants with and without AOS and between participants with and without dysarthria. Spearman rank correlations were calculated between ASRS-3 scores and clinical judgments of AOS and dysarthria severity and between MSDSR and CES ratings. Results Nine participants (12%) had normal speech. Eighty-seven percent exhibited dysarthria; hypokinetic and mixed hypokinetic–spastic dysarthria were observed most frequently. AOS was observed in 19.5% of participants across all variants, but in only 10% exclusive of the PSP speech and language variant. Nearly half presented with AOS in which neither phonetic nor prosodic features clearly predominated. The mean ASRS-3 score for participants with AOS was significantly higher than for those without and correlated strongly with clinician judgment of AOS severity. Mean ASRS-3 was higher for participants with dysarthria than for those without but correlated weakly with dysarthria severity. Mean MSDSR and CES ratings were lower in participants with AOS compared to those without and moderately correlated with each other. Conclusions Motor speech disorders that negatively impact communicative effectiveness are common in PSP and occur in many variants. This is the first description of motor speech disorders across PSP variants, setting the stage for future research characterizing neuroanatomical correlates, progression of motor speech disorders, and benefits of targeted interventions. Supplemental Material https://doi.org/10.23641/asha.14111837
Awareness of myeloma care and the global impact of treatment: An international internet-based prospective study
Ailawadhi, Sikander , Swaika, Abhisek, Advani, Pooja , Hodge, David O. , Paulus, Aneel , Khera, Nandita , Hashmi, Shahrukh K. , Alegria, Victoria R., Abdulazeez, Mays F , Bodepudi, Srilekha, Jamwal, Khushi, Sher, Taimur , Chanan‐Khan, Asher , Ailawadhi, Meghna, Hodge, David, Abdulazeez, Mays, Chanan-Khan, Asher, Ailawadhi, Sikander , Paulus, Aneel , Roy, Vivek

Mayo Clinic

Journal of Oncology Pharmacy Practice | March 10, 2021 | Volume: 28 | Issue: 2 | Pages: 425-433

10.1177/10781552211001928 | PMID 33719723 Get It

Objective Outcomes in multiple myeloma (MM) have significantly improved necessitating focus on survivorship. Methods We undertook a web-based survey in collaboration with International Myeloma Foundation (IMF) to explore patient awareness and psycho-physical impacts of MM. The survey was viewed on the IMF website by 1,324 individuals from 32 countries. Results The survey responses were available from 959 individuals, with 62% who completed the survey. Treating doctors were the most frequent source of MM-related information. Only 56% patients admitted full compliance with treatment. Treatment side effects bothered 86% responders, including >50% admitting to pain, peripheral neuropathy and asthenia. Majority (57%) reported some degree of depression, 82% had discontent with their quality of life and only 35% reported being satisfied with their coping mechanisms. Patients ≥65 years of age reported more peripheral neuropathy (p = 0.007) and difficulty with ability to work (p = 0.015). Conclusions We report the prevalence of psychologic, social and physical domains as well as patient-physician relationship dynamics. This knowledge can help improve MM survivorship.Introduction
Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening
Pollock, Benjamin D. , Shah, Nilay D. , Farrugia, Gianrico , Virk, Abinash , Swift, Melanie D. , Breeher, Laura E. , Binnicker, Matthew J. , Berbari, Elie F. , Swift, Melanie, Breeher, Laura, Binnicker, Matthew, Swift, Melanie D , Pollock, Benjamin D , Tande, Aaron J. , Breeher, Laura

Mayo Clinic

Clinical Infectious Diseases | March 9, 2021 | Volume: 74 | Issue: 1 | Pages: 59-65

10.1093/cid/ciab229 | PMID 33704435 Get It

Abstract Background Several vaccines are now available under emergency use authorization in the United States and have demonstrated efficacy against symptomatic COVID-19. Vaccine impact on asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is largely unknown. Methods We conducted a retrospective cohort study of consecutive, asymptomatic adult patients (n = 39 156) within a large US healthcare system who underwent 48 333 preprocedural SARS-CoV-2 molecular screening tests between 17 December 2020 and 8 February 2021. The primary exposure of interest was vaccination with ≥1 dose of an mRNA COVID-19 vaccine. The primary outcome was relative risk (RR) of a positive SARS-CoV-2 molecular test among those asymptomatic persons who had received ≥1 dose of vaccine compared with persons who had not received vaccine during the same time period. RR was adjusted for age, sex, race/ethnicity, patient residence relative to the hospital (local vs nonlocal), healthcare system regions, and repeated screenings among patients using mixed-effects log-binomial regression. Results Positive molecular tests in asymptomatic individuals were reported in 42 (1.4%) of 3006 tests and 1436 (3.2%) of 45 327 tests performed on vaccinated and unvaccinated patients, respectively (RR, .44; 95% CI, .33–.60; P &lt; .0001). Compared with unvaccinated patients, risk of asymptomatic SARS-CoV-2 infection was lower among those &gt;10 days after the first dose (RR, .21; 95% CI, .12–.37; P &lt; .0001) and &gt;0 days after the second dose (RR, .20; 95% CI, .09–.44; P &lt; .0001) in the adjusted analysis. Conclusions COVID-19 vaccination with an mRNA-based vaccine showed a significant association with reduced risk of asymptomatic SARS-CoV-2 infection as measured during preprocedural molecular screening. Results of this study demonstrate the impact of the vaccines on reduction in asymptomatic infections supplementing the randomized trial results on symptomatic patients.
Whole-Transcriptome Analysis by RNA Sequencing for Genetic Diagnosis of Mendelian Skin Disorders in the Context of Consanguinity
Youssefian, Leila , Saeidian, Amir Hossein , Palizban, Fahimeh , Bagherieh, Atefeh , Abdollahimajd, Fahimeh , Sotoudeh, Soheila , Mozafari, Nikoo , Farahani, Rahele A., Zabihi, Masoud , Fortina, Paolo , Salas‐Alanís, Julio C., Vahidnezhad, Hassan , Uitto, Jouni , Mahmoudi, Hamidreza , Babashah, Sadegh , Zeinali, Sirous , South, Andrew P.

Mayo Clinic

Clinical Chemistry | March 9, 2021 | Volume: 67 | Issue: 6 | Pages: 876-888

10.1093/clinchem/hvab042 | PMID 33969388 Get It

Abstract Background Among the approximately 8000 Mendelian disorders, &gt;1000 have cutaneous manifestations. In many of these conditions, the underlying mutated genes have been identified by DNA-based techniques which, however, can overlook certain types of mutations, such as exonic-synonymous and deep-intronic sequence variants. Whole-transcriptome sequencing by RNA sequencing (RNA-seq) can identify such mutations and provide information about their consequences. Methods We analyzed the whole transcriptome of 40 families with different types of Mendelian skin disorders with extensive genetic heterogeneity. The RNA-seq data were examined for variant detection and prioritization, pathogenicity confirmation, RNA expression profiling, and genome-wide homozygosity mapping in the case of consanguineous families. Among the families examined, RNA-seq was able to provide information complementary to DNA-based analyses for exonic and intronic sequence variants with aberrant splicing. In addition, we tested the possibility of using RNA-seq as the first-tier strategy for unbiased genome-wide mutation screening without information from DNA analysis. Results We found pathogenic mutations in 35 families (88%) with RNA-seq in combination with other next-generation sequencing methods, and we successfully prioritized variants and found the culprit genes. In addition, as a novel concept, we propose a pipeline that increases the yield of variant calling from RNA-seq by concurrent use of genome and transcriptome references in parallel. Conclusions Our results suggest that “clinical RNA-seq” could serve as a primary approach for mutation detection in inherited diseases, particularly in consanguineous families, provided that tissues and cells expressing the relevant genes are available for analysis.